GlaxoSmithKline plc (ADR) news

   Watch this stock
Showing stories 1 - 10 of about 167   

Articles published

GSK 44.99 -0.17 (-0.38%)
price chart
Company News: GlaxoSmithKline plc (ADR) (NYSE:GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK) announced the simultaneous availability of two of its recently approved products for the treatment of asthma and COPD to retail pharmacies in the US.
GlaxoSmithKline plc (ADR) Witness Large Outflow of Money  Stafford Daily
Analyst Price Target Consensus on GlaxoSmithKline plc (ADR)  Wall Street Pulse
Are Glaxosmithkline Plc (ADR) (NYSE:GSK) And Pfizer Inc. (NYSE:PFE ...
Doctors without Borders recently blamed GlaxoSmithKline plc (ADR) (NYSE:GSK) and Pfizer Inc. (NYSE:PFE) for overcharging vaccine prices in developing countries, making them unaffordable for certain countries.
GSK, Pfizer Forced To Slash Vaccine Prices In Developing Countries  Bidness ETC
Stock News: GlaxoSmithKline plc (ADR) (NYSE:GSK)
GlaxoSmithKline plc (ADR) (NYSE:GSK), which last year stated that it was exploring the potential for an IPO of a minority shareholding in its ViiV Healthcare business focused on HIV, said it could consider more partial public offerings for units ...
GlaxoSmithKline plc Receives Overweight Rating from Barclays  Intercooler
GlaxoSmithKline plc Given "Hold" Rating at Deutsche Bank  Dakota Financial News
Analyst Update: Alcatel Lucent SA (ADR), AT&T Inc., and GlaxoSmithKline plc ...
Analysts are weighing in today on networking firm Alcatel Lucent SA (ADR) (NYSE:ALU), telecom issue AT&T Inc. (NYSE:T), and pharmaceutical power GlaxoSmithKline plc (ADR) (NYSE:GSK). Here's a quick look at today's brokerage notes on ALU, T, and ...
Related articles »  
GlaxoSmithKline plc (ADR) (NYSE:GSK) Buys Stake in Aspen Pharmacare's ...
GlaxoSmithKline plc (ADR) (NYSE:GSK) the U.K.'s biggest drugmaker, will take a stake in the Japanese subsidiary of Aspen Pharmacare Holdings Ltd.
Related articles »  
GlaxoSmithKline plc (ADR) Receives Analyst Recommendation
GlaxoSmithKline downgraded to Underweight from Neutral at JPMorgan. JPMorgan downgraded GlaxoSmithKline to Underweight citing negative earnings momentum and limited upcoming newsflow.
GlaxoSmithKline plc (ADR) Sees Largest Inflow of Money  Bar and Graph Report
Stocks to Keep Eyes On: GlaxoSmithKline (NYSE:GSK), Verizon ...  Property Mentor
Related articles »  
Best Pharma Stocks Not In The U.S. [GlaxoSmithKline plc (ADR), AbbVie Inc ...
1 Must Own Pharma Stock: GlaxoSmithKline PLC (NYSE: GSK). As mentioned, one of the more enticing aspects to these international drug companies is there �cheapness� relative to U.S.
Buzz Stocks: GlaxoSmithKline plc (ADR), Valeant Pharmaceuticals Intl Inc, and ...
Futures are pointed higher this morning, ahead of the Federal Open Market Committee's (FOMC) latest meeting minutes and the unofficial start of earnings season.
Related articles »  
Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (ADR) (NYSE:GSK), Sanofi SA ...
Security analysts are predicting that in near future, some giant companies that have highest yields on their dividends may be forced to cut it and names which are rumoring in the markets are Pfizer Inc. (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK ...
Are GlaxoSmithKline's (GSK) Restructuring Efforts Enough For Investors?  Bidness ETC
Related articles »  
GlaxoSmithKline plc (GSK) Traders Respond to Ebola News
GlaxoSmithKline plc (ADR) (NYSE:GSK) is 0.4% higher at $45.15, following news that clinical trials of the company's Ebola vaccine will begin shortly in Liberia.